Researchers have made a significant breakthrough in developing a new gene therapy approach that restores full-length dystrophin protein, which could lead to new treatments for people with Duchenne muscular dystrophy (DMD).
Categories
Recent Posts
- How to Manage Stress and Fear in Uncertain Times
- Satellos Announces Positive Functional Data from Phase 1b Open-Label Trial of SAT-3247 in Adults with Duchenne
- Investigational gene therapy shows benefits in two boys with DMD
- Florida Signs Duchenne Newborn Screening into Law
- MDA Conference Grants Support Resources to the Community